Schedule 13G ownership disclosure
LB Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 50180M108
Event date: 2025-09-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 1,675,000.00 · Class: 7.5%
- Peter Kolchinsky
Shares: 1,675,000.00 · Class: 7.5%
- Rajeev Shah
Shares: 1,675,000.00 · Class: 7.5%
- RA Capital Healthcare Fund, L.P.
Shares: 1,675,000.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000005
- Form type
- SCHEDULE 13G
- Filer
- LB PHARMACEUTICALS INC
- CIK
- CIK 1691082
- Filed
- Sep 19, 2025
- Reporting period
- Sep 12, 2025
- Description
- Schedule 13G beneficial ownership